---
title: "NHS National Generic Pharmaceuticals Wave 13"
ocid: "ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "ATAMIS LTD"
published: "2022-01-19"
---

# NHS National Generic Pharmaceuticals Wave 13

Buyer: ATAMIS LTD  
Current stage: Award  
OCID: ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100.json)

## Summary

The procurement process for the "NHS National Generic Pharmaceuticals Wave 13" was managed by ATAMIS LTD, a key contracting authority in the healthcare sector. This procurement falls under the pharmaceutical products category and involves a framework agreement that has a total maximum duration of 28 months, with the possibility of extension up to 48 months. Key dates include the contract start date of 1st February 2022 and an end date of 31st May 2024. The tender was conducted using an open procurement method, with an estimated value of £469,741,550 and delivery expected across multiple regions of the United Kingdom.

This tender presents significant business growth opportunities for companies in the pharmaceutical sector, especially those that can deliver generic medicines. Small and medium-sized enterprises (SMEs) are particularly well-suited to participate, as the procurement specifies suitability for SMEs. Competitors such as Pfizer Ltd and GlaxoSmithKline UK Limited, along with numerous other suppliers, highlight the competitive landscape. Businesses should be prepared to meet the quality and regulatory standards required by the NHS to successfully bid for this contract.

## Notice

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/2b45447f-b07a-4024-8b3a-2a2f2fd86749 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (below threshold) |
| Tender suitability | SME |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 19 Jan 2022 |
| Submission deadline | 26 Jul 2021 |
| Future notice date | Not specified |
| Award date | 30 Nov 2021 |
| Contract period | 1 Feb 2022 - 31 May 2024 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £469,741,550 |
| Lots value | Not specified |
| Awards value | £469,741,550 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Cancelled |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | ATAMIS LTD |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 99 |
| Supplier names | ACCORD-UK; ACIUM; AGUETTANT; ALISSA HEALTHCARE RESEARCH; ALLERGAN; ALLIANCE PHARMACEUTICALS; ALTAN PHARMA; AMAROX; AOP ORPHAN; ARCADIA PHARMA LTD T/A ARCADIA MEDICAL; ARISTO PHARMA; ASCEND LABORATORIES; ASPEN PHARMACARE; ASPIRE PHARMA; AVENTIS PHARMA LTD T/A SANOFI; B. BRAUN MEDICAL; BAXTER HEALTHCARE; BAYER; BOWMED IBISQUS; BRISTOL LABORATORIES; BROWN & BURK; CIPLA (EU; COLONIS PHARMA; CONSILIENT HEALTH; CRESCENT PHARMA; CST PHARMA; DAY LEWIS MEDICAL; DERMA; DESITIN PHARMA; DEXCEL PHARMA; DR FALK PHARMA; DR.REDDY'S LABORATORIES (UK; DRUGSRUS; ENNOGEN HEALTHCARE; FERRING PHARMACEUTICALS; FLEXIPHARM AUSTRADING; FONTUS HEALTH; FRESENIUS KABI; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMA; HEALTHCARE PHARMA; KENSINGTON PHARMA; KENT PHARMA; KYOWA KIRIN; LABORATORIO REIG JOFRE; LEO PHARMA; LOGIXX PHARMA; LUCANE PHARMA; LUNDBECK; LUPIN HEALTHCARE (UK; MACLEODS PHARMA; MACURE PHARMA; MANX HEALTHCARE; MARTINDALE PHARMA; MEDAC PHARMA; MEDREICH; MERCK SHARPE & DOHME (UK; MERCURY PHARMACEUTICALS; MILPHARM LTD/AUROBINBDO; MIP PHARMA; MORNINGSIDE PHARMAEUTICALS; MYLAN; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NEXCAPE PHARMACEUTICALS; NORGINE PHARMACEUTICALS; ORGANON PHARMACEUTICALS; PANPHARMA; PARI; PFIZER; PIERRE FABRE; PROFILE PHARMA; RANBAXY; RECKITT BENCKISER; RECORDATI RARE DISEASES; RELONCHEM; RIVOPHARM; ROCHE PRODUCTS; ROMA PHARMACEUTICALS; ROSEMONT PHARMACEUTICALS; RPH PHARMACEUTICALS; SANDOZ; SEACROSS PHARMACEUTICALS; SELECTIVE SUPPLIES; STRAGEN; STRIDES PHARMA; SYNCHRONY; SYRI LIMITED (T/A THAME LABORATORIES; TEVA; THEA PHARMACEUTICALS; THORNTON AND ROSS; TORBAY PHARMACEUTICALS; TORRENT PHARMA; V PHARMA; WAVERLEY PHARMA EUROPE; WOCKHARDT; ZENTIVA PHARMA; ZISTA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 19 Jan 2022 at 14:51 - TenderCancellation - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/2b45447f-b07a-4024-8b3a-2a2f2fd86749
- 19 Jan 2022 at 14:45 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/ee32813d-4145-4095-9b85-76f04cacfd6b

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/2b45447f-b07a-4024-8b3a-2a2f2fd86749
  19th January 2022 - Opportunity notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/ee32813d-4145-4095-9b85-76f04cacfd6b
  19th January 2022 - Awarded contract notice on Contracts Finder

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100.json.